Haemonetics (HAE) Earnings Date, Estimates & Call Transcripts $85.26 -2.22 (-2.54%) (As of 12/3/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Haemonetics Latest Earnings SummaryUpcoming Q3 Earnings DateFeb. 13EstimatedActual EPS (Nov. 7) $1.12 Beat By $0.03 Consensus EPS (Nov. 7) $1.09 Haemonetics announced Q2 2025 earnings on November 7, 2024, reporting an EPS of $1.12, which beat the consensus estimate of $1.09 by $0.03. Quarterly revenue rose 8.6% year-over-year to $345.50 million, above analysts' expectations of $342.57 million. With a trailing EPS of $2.41 and a P/E Ratio of 35.38, Haemonetics' earnings are expected to grow 13.94% next year, from $4.59 to $5.23 per share. Conference Call TranscriptConference Call AudioSEC 10-Q/10-K FilingPowered by HAE Upcoming EarningsHaemonetics' next earnings date is estimated for Thursday, February 13, 2025, based off prior year's reporting schedules. Get Haemonetics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haemonetics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHAE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HAE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceExpert: The most important message you’ll see in 2024The message I'm sharing today could be the most important message of 2024. In short, America is being invaded… The invasion spreading across America is coming from the ports, highways, and railroads.Click here to see how before it's too late. Haemonetics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.65$0.74$0.70 Q2 20242$0.91$0.93$0.92 Q3 20242$0.95$0.96$0.96 Q4 20242$0.87$0.88$0.88 FY 20248$3.38$3.51$3.45 Q1 20252$1.02$1.03$1.03 Q2 20252$1.09$1.10$1.10 Q3 20252$1.14$1.19$1.17 Q4 20252$1.26$1.27$1.27 FY 20258$4.51$4.59$4.55 Q1 20262$1.16$1.18$1.17 Q2 20262$1.24$1.29$1.27 Q3 20262$1.32$1.35$1.34 Q4 20262$1.40$1.41$1.41 FY 20268$5.12$5.23$5.18 Q1 20271$1.48$1.48$1.48 Haemonetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/13/2025(Estimated)-------11/7/2024Q2 2025$1.09$1.12+$0.03$1.58$342.57M$345.50M8/8/2024Q1 2025$1.03$1.02 -$0.01$1.30$335.08M$336.17M5/9/2024Q4 2024$0.88$0.90+$0.02$1.40$329.53M$343.00M2/8/2024Q4 2023$0.94$1.04+$0.10$1.47$320.84M$336.20M11/2/2023Q2 2024$0.94$0.99+$0.05$1.50$319.18M$318.18M8/8/2023Q2 2023$0.73$1.05+$0.32$1.30$292.74M$311.30M Get the Latest News and Ratings for HAE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Haemonetics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q4 2023$0.68$0.77+$0.09$0.97$284.53M$304.42M2/7/2023Q3 2023$0.79$0.85+$0.06$1.06$300.47M$305.30M Haemonetics Earnings - Frequently Asked Questions When is Haemonetics's earnings date? Haemonetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on HAE's earnings history. What guidance has Haemonetics issued on next quarter's earnings? Haemonetics updated its FY 2025 earnings guidance on Thursday, November, 7th. The company provided EPS guidance of 4.450-4.750 for the period, compared to the consensus earnings per share estimate of 4.590. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Did Haemonetics beat their earnings estimates last quarter? In the previous quarter, Haemonetics (NYSE:HAE) reported $1.12 earnings per share (EPS) to beat the analysts' consensus estimate of $1.09 by $0.03. Learn more on analysts' earnings estimate vs. HAE's actual earnings. How can I listen to Haemonetics's earnings conference call? The conference call for Haemonetics's latest earnings report can be listened to online. Listen to Conference Call How can I read Haemonetics's conference call transcript? The conference call transcript for Haemonetics's latest earnings report can be read online. Read Transcript How can I view Haemonetics's earnings report? Haemonetics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Haemonetics generate each year? Haemonetics (NYSE:HAE) has a recorded annual revenue of $1.31 billion. How much profit does Haemonetics generate each year? Haemonetics (NYSE:HAE) has a recorded net income of $117.56 million. HAE has generated $2.41 earnings per share over the last four quarters. What is Haemonetics's price-to-earnings ratio? Haemonetics (NYSE:HAE) has a trailing price-to-earnings ratio of 35.38 and a forward price-to-earnings ratio of 18.58. The price/earnings-to-growth ratio is 1.36. What is Haemonetics's EPS forecast for next year? Haemonetics's earnings are expected to grow from $4.59 per share to $5.23 per share in the next year, which is a 13.94% increase. More Earnings Resources from MarketBeat Related Companies Align Technology Earnings Date Merit Medical Systems Earnings Date ICU Medical Earnings Date DENTSPLY SIRONA Earnings Date Neogen Earnings Date QuidelOrtho Earnings Date STAAR Surgical Earnings Date Cerus Earnings Date OraSure Technologies Earnings Date Anika Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Expert: The most important message you’ll see in 2024 (Ad)The message I'm sharing today could be the most important message of 2024. In short, America is being invaded… The invasion spreading across America is coming from the ports, highways, and railroads.Click here to see how before it's too late. This page (NYSE:HAE) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHas World War III already started?As global tensions are rising, so does the potential of direct conflict between the US and China. That's wh...Behind the Markets | SponsoredMeet the NYSE traded company behind a potentially blockbuster antiviral drugThis public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HAE Stock Alerts